BioPontis, University of Kansas deal

The university partnered with BioPontis, which said it is focused on translating university research into clinical candidates for pharmas to treat cancer, infectious and inflammation diseases and neurological indications. BioPontis is partnered with at least seven universities, including Columbia University, New York University and the Memorial Sloan Kettering Cancer Center. Terms were not disclosed. ...